Translate Bio, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$3.71B

161 transactions

Summary

Translate Bio, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $2.75BSales: $269.2M40 insiders

Date	Insider	Type	Value
2021-09-14	Sanofi	Buy	$1.96B
2021-09-14	Sanofi	Buy	$779.6M
2021-09-14	FORMELA JEAN FRANCOIS	Sell	$78.1M
2021-09-14	Beckman Daniella	Sell	$0
2021-09-14	Beckman Daniella	Sell	$0
2021-09-14	Beckman Daniella	Sell	$0
2021-09-14	Beckman Daniella	Sell	$0
2021-09-14	Demetri George	Sell	$0
2021-09-14	Demetri George	Sell	$0
2021-09-14	Demetri George	Sell	$0
2021-09-14	FORMELA JEAN FRANCOIS	Sell	$0
2021-09-14	FORMELA JEAN FRANCOIS	Sell	$0
2021-09-14	FORMELA JEAN FRANCOIS	Sell	$0
2021-09-14	FORMELA JEAN FRANCOIS	Sell	$0
2021-09-14	Demetri George	Sell	$0
2021-09-14	Demetri George	Sell	$0
2021-09-14	Demetri George	Sell	$0
2021-09-14	Hughes Owen	Sell	$0
2021-09-14	Hughes Owen	Sell	$0
2021-09-14	Hughes Owen	Sell	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Translate Bio, Inc. — Contributions, Lobbying & Contracts | Poliscope